141 related articles for article (PubMed ID: 29623853)
1. Repositioning of Difluorinated Propanediones as Inhibitors of Histone Methyltransferases and their Biological Evaluation in Human Leukemic Cell Lines.
Pal T; Sharda A; Khade B; Ramaa CS; Gupta S
Anticancer Agents Med Chem; 2018; 18(13):1892-1899. PubMed ID: 29623853
[TBL] [Abstract][Full Text] [Related]
2. Quinoline-based p300 histone acetyltransferase inhibitors with pro-apoptotic activity in human leukemia U937 cells.
Lenoci A; Tomassi S; Conte M; Benedetti R; Rodriguez V; Carradori S; Secci D; Castellano S; Sbardella G; Filetici P; Novellino E; Altucci L; Rotili D; Mai A
ChemMedChem; 2014 Mar; 9(3):542-8. PubMed ID: 24504685
[TBL] [Abstract][Full Text] [Related]
3. Biological evaluation of tanshindiols as EZH2 histone methyltransferase inhibitors.
Woo J; Kim HY; Byun BJ; Chae CH; Lee JY; Ryu SY; Park WK; Cho H; Choi G
Bioorg Med Chem Lett; 2014 Jun; 24(11):2486-92. PubMed ID: 24767850
[TBL] [Abstract][Full Text] [Related]
4. Novel Anthraquinone Derivatives as Dual Inhibitors of Topoisomerase 2 and Casein Kinase 2: In Silico Studies, Synthesis and Biological Evaluation on Leukemic Cell Lines.
Kabir A; Tilekar K; Upadhyay N; Ramaa CS
Anticancer Agents Med Chem; 2018; 18(11):1551-1562. PubMed ID: 29683096
[TBL] [Abstract][Full Text] [Related]
5. Identification and Characterizations of Novel, Selective Histone Methyltransferase SET7 Inhibitors by Scaffold Hopping- and 2D-Molecular Fingerprint-Based Similarity Search.
Ding H; Lu WC; Hu JC; Liu YC; Zhang CH; Lian FL; Zhang NX; Meng FW; Luo C; Chen KX
Molecules; 2018 Mar; 23(3):. PubMed ID: 29498708
[TBL] [Abstract][Full Text] [Related]
6. Identification of PR-SET7 and EZH2 selective inhibitors inducing cell death in human leukemia U937 cells.
Valente S; Lepore I; Dell'Aversana C; Tardugno M; Castellano S; Sbardella G; Tomassi S; Di Maro S; Novellino E; Di Santo R; Costi R; Altucci L; Mai A
Biochimie; 2012 Nov; 94(11):2308-13. PubMed ID: 22709867
[TBL] [Abstract][Full Text] [Related]
7. 5-Aminonaphthalene derivatives as selective nonnucleoside nuclear receptor binding SET domain-protein 2 (NSD2) inhibitors for the treatment of multiple myeloma.
Wang S; Yang H; Su M; Lian F; Cong Z; Wei R; Zhou Y; Li X; Zheng X; Li C; Fu X; Han X; Shi Q; Li C; Zhang N; Geng M; Liu H; Li J; Huang X; Wang J
Eur J Med Chem; 2021 Oct; 222():113592. PubMed ID: 34147909
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological activity of 4-(4-benzyloxy)phenoxypiperidines as selective and reversible LSD1 inhibitors.
Xi J; Xu S; Zhang L; Bi X; Ren Y; Liu YC; Gu Y; Xu Y; Lan F; Zha X
Bioorg Chem; 2018 Aug; 78():7-16. PubMed ID: 29524666
[TBL] [Abstract][Full Text] [Related]
9. A trifluorinated thiazoline scaffold leading to pro-apoptotic agents targeting prohibitins.
Pérez-Perarnau A; Preciado S; Palmeri CM; Moncunill-Massaguer C; Iglesias-Serret D; González-Gironès DM; Miguel M; Karasawa S; Sakamoto S; Cosialls AM; Rubio-Patiño C; Saura-Esteller J; Ramón R; Caja L; Fabregat I; Pons G; Handa H; Albericio F; Gil J; Lavilla R
Angew Chem Int Ed Engl; 2014 Sep; 53(38):10150-4. PubMed ID: 25196378
[TBL] [Abstract][Full Text] [Related]
10. Drug screening approach combines epigenetic sensitization with immunochemotherapy in cancer.
Facciotto C; Casado J; Turunen L; Leivonen SK; Tumiati M; Rantanen V; Kauppi L; Lehtonen R; Leppä S; Wennerberg K; Hautaniemi S
Clin Epigenetics; 2019 Dec; 11(1):192. PubMed ID: 31829282
[TBL] [Abstract][Full Text] [Related]
11. Identification of (R)-N-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide (CPI-1205), a Potent and Selective Inhibitor of Histone Methyltransferase EZH2, Suitable for Phase I Clinical Trials for B-Cell Lymphomas.
Vaswani RG; Gehling VS; Dakin LA; Cook AS; Nasveschuk CG; Duplessis M; Iyer P; Balasubramanian S; Zhao F; Good AC; Campbell R; Lee C; Cantone N; Cummings RT; Normant E; Bellon SF; Albrecht BK; Harmange JC; Trojer P; Audia JE; Zhang Y; Justin N; Chen S; Wilson JR; Gamblin SJ
J Med Chem; 2016 Nov; 59(21):9928-9941. PubMed ID: 27739677
[TBL] [Abstract][Full Text] [Related]
12. Discovery of potent DOT1L inhibitors by AlphaLISA based High Throughput Screening assay.
Song Y; Li L; Chen Y; Liu J; Xiao S; Lian F; Zhang N; Ding H; Zhang Y; Chen K; Jiang H; Zhang C; Liu YC; Chen S; Luo C
Bioorg Med Chem; 2018 May; 26(8):1751-1758. PubMed ID: 29534934
[TBL] [Abstract][Full Text] [Related]
13. Covalent inhibitors of EZH2: Design, synthesis and evaluation.
Zhang Q; Chen X; Hu X; Duan X; Wan G; Li L; Feng Q; Zhang Y; Wang N; Yu L
Biomed Pharmacother; 2022 Mar; 147():112617. PubMed ID: 34998031
[TBL] [Abstract][Full Text] [Related]
14. Drugging histone methyltransferases in cancer.
Richart L; Margueron R
Curr Opin Chem Biol; 2020 Jun; 56():51-62. PubMed ID: 31981999
[TBL] [Abstract][Full Text] [Related]
15. From a multipotent stilbene to soluble epoxide hydrolase inhibitors with antiproliferative properties.
Buscató E; Büttner D; Brüggerhoff A; Klingler FM; Weber J; Scholz B; Zivković A; Marschalek R; Stark H; Steinhilber D; Bode HB; Proschak E
ChemMedChem; 2013 Jun; 8(6):919-23. PubMed ID: 23596124
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of novel 2-aminobenzamides containing dithiocarbamate moiety as histone deacetylase inhibitors and potent antitumor agents.
Xie R; Li Y; Tang P; Yuan Q
Eur J Med Chem; 2018 Jan; 143():320-333. PubMed ID: 29202397
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of cytotoxic 2,2-difluoroderivatives of dihydrobetulinic acid and allobetulin and study of their impact on cancer cells.
Borkova L; Jasikova L; Rehulka J; Frisonsova K; Urban M; Frydrych I; Popa I; Hajduch M; Dickinson NJ; Vlk M; Dzubak P; Sarek J
Eur J Med Chem; 2015; 96():482-90. PubMed ID: 25942059
[TBL] [Abstract][Full Text] [Related]
18. Positioning of an unprecedented 1,5-oxaza spiroquinone scaffold into SMYD2 inhibitors in epigenetic space.
Dhorma LP; Teli MK; Nangunuri BG; Venkanna A; Ragam R; Maturi A; Mirzaei A; Vo DK; Maeng HJ; Kim MH
Eur J Med Chem; 2022 Jan; 227():113880. PubMed ID: 34656041
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure-activity relationship studies of LLY-507 analogues as SMYD2 inhibitors.
Zhang B; Liao L; Wu F; Zhang F; Sun Z; Chen H; Luo C
Bioorg Med Chem Lett; 2020 Nov; 30(22):127598. PubMed ID: 33011288
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and anti leukemia cells proliferation activities of pyrimidylaminoquinoline derivatives as DOT1L inhibitors.
Zhang L; Chen Y; Liu N; Li L; Xiao S; Li X; Chen K; Luo C; Chen S; Chen H
Bioorg Chem; 2018 Oct; 80():649-654. PubMed ID: 30059890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
